Eurofins-Cerep SA

Eurofins-Cerep SA

Eurofins-Cerep SA

Overview
Date Founded

1990

Headquarters

Le bois l'Evêque,Celle l'Evescault, Nouvelle-Aquitaine 86600

Type of Company

Public

Employees (Worldwide)

146

Industries

Other Business & Consulting Services
Pharmaceuticals

Company Description

Eurofins-Cerep SA engages in providing preclinical drug research services. The firm’s BioPrint, allows the modeling of clinical effects of drug candidates from molecular properties. Its services include compound management, high-throughput screening, in vitro safety profiling, assay development, and profile design. The company was founded by Thierry Jean on December 20, 1989 and is headquartered in Celle l'Evescault, France.

Executives & Employees

Founder

Chief Executive Officer & Director

Board of Directors

Managing Director at Eurofins DiscoverX Corp.

President & Director at Eurofins Panlabs, Inc.

Chief Executive Officer & Director at Eurofins-Cerep SA

Paths to Eurofins-Cerep SA
Potential Connections via
Relationship Science
You
Eurofins-Cerep SA
Transaction Advisors
Accountant

Advised onEurofins-Cerep SA purchases Hesperion AG from Actelion Ltd.

Key Stats and Financials As of 2019
Market Capitalization
$84.7M
Total Enterprise Value
$31.9M
Earnings Per Share
$990.47
EBITDAMargin
17.42%
Enterprise Value / Sales
0.9x
Enterprise Value EBITDAOperating
5.17x
TEVNet Income
6.39x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
9.78%
Five Year Compounded Annual Growth Rate Of Revenue
10.88%
Revenue
$35.4M
Net Profit
$5M
EBITDA
$6.17M
Total Debt
$5,900
Total Equity
$33.9M
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Eurofins-Cerep SA. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Eurofins-Cerep SA's profile does not indicate a business or promotional relationship of any kind between RelSci and Eurofins-Cerep SA.